Clinical trial
A Randomized, Double-Blind, Three-Arm, Prospective, Single-Center Clinical Study to Evaluate the Safety, Efficacy, and Tolerability of Pinorox® in Subjects With Facial Signs of Aging
NCT07111156 is registered in ClinicalTrials.gov with NovoBliss Research Pvt Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Three-Arm, Prospective, Single-Center Clinical Study to Evaluate the Safety, Efficacy, and Tolerability of Pinorox® in Subjects With Facial Signs of Aging
- Lead sponsor
- NovoBliss Research Pvt Ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 16, 2025
- Completion date
- February 17, 2026
- Enrollment
- 81 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
facial sign of aging, fine lines, wrinkles